Prevalence of germline brca1/2 variants in ashkenazi and non-ashkenazi prostate cancer populations: a systematic review and meta-analysis

HIGHLIGHTS

• who: Antonio Cioffi and colleagues from the Division of Urology, European Institute of Oncology (IEO), IRCCS, Milan, Italy Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy have published the paper: Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis, in the Journal: Cancers 2023, 306 of /2023/
• what: Ashkenazi Jewish ancestry was associated with BRCA1/2 variants in men with PCa, with a prevalence of BRCA2 (1-3%) [20,26,30].
• how: For the meta-analysis the authors used . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.